In the field of wearable devices, Huawei is no longer a mere follower, but a rule-maker. From the early introduction of TruSeen heart rate monitoring technology to the pioneering micro-pump liquid blood pressure measurement, Huawei has always maintained an aggressive exploratory stance in the health track of smartwatches.
Huawei’s WATCH series product line has a clear layout: the GT series focuses on long battery life and professional sports performance, the digital series focuses on all-around flagship features and eSIM independent communication, while the Ultimate series targets extreme outdoor activities and luxurious features. However, facing the increasingly serious needs of chronic disease management, especially the pain points of people with hypertension and hyperglycemia, Huawei has once again broken boundaries and launched the Huawei CH Air Pump Blood Pressure and Blood Glucose Monitoring Smartwatch (hereinafter referred to as “CH Watch”), which integrates revolutionary sensing technology. This is not only a hardware iteration, but also a strategic milestone for Huawei in bringing medical-grade monitoring capabilities from the “clinic” to “daily life”.
Product Positioning & Key Highlights Overview
CH Watch has a very clear product positioning: the first comprehensive health management terminal for the global mass consumer market with medical-grade non-invasive/minimally invasive trend monitoring capabilities.
It’s no longer just an accessory for tracking steps or sending notifications; it’s a “personal health manager” on your wrist, specifically designed for middle-aged and elderly individuals highly sensitive to fluctuations in blood pressure and blood sugar, as well as those in sub-healthy working environments. Its core strengths can be summarized as “dual-core drive, precise breakthrough”:
Miniature Air Pump Blood Pressure Measurement System: Building upon the success of Huawei’s WATCH D series and further miniaturizing it, this system measures blood pressure directly using the oscillometric method by inflating a miniature air bladder within the watch band, rather than relying on optical estimation. This means it can obtain Class II medical device registration certifications from multiple drug regulatory agencies, and the data has clinical reference value, completely solving the industry-wide problem of traditional photoelectric watches being “inaccurate and unreliable” in blood pressure measurement.
High blood sugar risk assessment algorithm: This is the most revolutionary feature of the CH watch. Although limited by the laws of physics, it is not yet possible to achieve completely non-invasive absolute measurement, Huawei’s AI algorithm, trained with multimodal sensors (PPG, skin temperature, heart rate variability, etc.) and massive clinical data, can assess the risk level of high blood sugar in real time and issue warnings when abnormal trends are detected. This greatly reduces the pain for diabetic patients who need frequent injections and provides valuable continuous trend references.
24/7 Health Closed Loop: In addition to blood pressure and blood sugar, it also integrates ECG electrocardiogram analysis, vascular elasticity detection, sleep apnea screening and other functions, building a complete health monitoring closed loop from the cardiovascular system to the metabolic system.
Configuration parameters and hardware analysis
To support such powerful health monitoring capabilities, the CH watch spared no expense in terms of hardware components, demonstrating Huawei’s profound engineering expertise.
Sensor Array: The back of the watch features an upgraded TruSense ultra-sensing module. This includes a miniature air pump and a high-precision pressure sensor for blood pressure measurement. The air pump is 30% smaller than its predecessor and its noise level is reduced by 15 decibels. A multi-channel PPG sensor for blood glucose risk assessment has increased the sampling rate to hundreds of times per second. Combined with the newly added skin electrochemical sensor, this significantly improves the signal-to-noise ratio of biological signals.
Screen and Interaction: Equipped with a 1.82-inch AMOLED high-definition retina display with a peak brightness of 2000 nits, blood pressure values can be clearly read even in bright sunlight. The UI design has been optimized for middle-aged and elderly users, with larger fonts and key health data displayed at a glance. It supports both full-screen touch and physical rotating crown operation, allowing for easy operation even when wearing gloves or with wet hands.
Battery Life and Charging: Despite the power-intensive built-in micro-pump, the CH watch maintains an impressive energy efficiency ratio. Under typical usage, it lasts up to 7 days, and even with intensive blood pressure monitoring, it can last for 4 days. It supports wireless fast charging; a 10-minute charge is sufficient for a day’s basic monitoring needs.
Structure and Materials: The watch body is crafted from aerospace-grade titanium alloy, making it lightweight yet robust. The strap is specifically designed for blood pressure measurement, using a memory polymer material that ensures a tight seal during inflation while remaining soft and breathable for everyday wear. The entire watch is 5ATM water-resistant, so it can be worn without removing it while washing hands or showering.
System Ecosystem: Runs HarmonyOS 4.2 and above, deeply integrated with the Huawei Health App. Data can be generated into weekly and monthly reports with one click, and can be exported in PDF format for doctors’ reference. It also supports family sharing, allowing children to remotely view real-time alerts for their parents’ health abnormalities.
Purchase Recommendations + Target Audience
The CH watch is not a “one-size-fits-all” watch suitable for everyone; its value is amplified in specific scenarios. Considering its high-end positioning and R&D costs, its initial international price is expected to be between $399 and $449. Highly recommended for the following groups:
For patients diagnosed with hypertension and high-risk individuals: For users who need to monitor their blood pressure multiple times a day, the CH watch is the best complement to traditional cuff blood pressure monitors. It can capture nighttime sleep blood pressure and morning peak blood pressure, which are often blind spots that traditional devices struggle to record. For an investment of nearly $400, you get 24/7 medical-grade protection, making it extremely cost-effective.
For those with prediabetes and those who need long-term blood sugar control: Although it cannot replace finger prick blood tests, its high blood sugar risk assessment function can effectively reduce unnecessary pricks, help users discover the impact of diet and exercise on blood sugar trends, and adjust their lifestyle in a timely manner.
For children concerned about their parents’ health: As a gift for elders, the CH watch’s “remote monitoring” function is extremely valuable. If parents experience a sudden spike in blood pressure or a risk of high blood sugar, their children’s phones will immediately receive an alert, truly realizing “love in the heart even when not physically present.”
High-pressure workplace elites: For middle-aged people who are at increased risk of metabolic syndrome due to long-term sleep deprivation and irregular eating habits, this is an essential early warning device.
Purchase Caution Notice:
If you’re looking for ultimate performance in sports (like professional triathlon data) or expect it to completely replace hospital blood tests, you might want to lower your expectations. Additionally, due to its air pump structure, it’s slightly thicker than a typical smartwatch, so users with very thin wrists should try it on before buying. For users on a budget, if basic heart rate monitoring is all that’s needed, there are cheaper alternatives on the market. However, when it comes to blood pressure and blood sugar management, the technological barriers of the CH watch are currently difficult for lower-priced products to overcome.
Summary : Huawei CH, your health management expert
After in-depth testing and data analysis, the Huawei CH Watch is undoubtedly one of the most comprehensive and technologically advanced smart wearable devices on the market. It doesn’t stop at the surface level of “monitoring data,” but delves into the core of “health management.” When you see it silently and accurately measure blood pressure through a miniature air pump, or keenly detect abnormal fluctuations in post-meal blood sugar through algorithms, you’ll marvel at the awe and care that technology shows for human life.
Of course, there is still room for technological improvement. For example, the personalized calibration process for blood glucose assessment could be further simplified, and the inflator’s feel could be even more gentle. However, these minor flaws do not detract from the overall excellence. The emergence of the CH watch marks the formal evolution of smartwatches from “toys” to extensions of “medical devices.”
In today’s rapidly aging society, we need more than just cold, hard data parameters; we need intelligent protection that can prevent problems before they arise. The significance of the Huawei CH Watch lies in democratizing professional testing capabilities, originally reserved for hospitals, to everyone’s wrist. It makes health management seamless, continuous, and reliable. This is not just the success of a product, but the best testament to technology for good—the best technology doesn’t make people aware of its presence, but allows them to forget the fear of disease and enjoy every moment with peace of mind under its protection. For families who value quality of life, even with a price tag of nearly $400, the CH Watch is not just an electronic product, but a weighty and irreplaceable commitment to health.
